02161.HK
JBM (Healthcare) Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 1.64
+0.00%Year over year
Reported trailing growth
- Revenue
- +6.7%
- EBITDA
- +5.0%
- EBIT
- +10.4%
- EPS
- +4.2%
- Free cash flow
- -42.0%
- Operating cash flow
- -32.7%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +17.1%
- EBITDA
- +39.7%
- EBIT
- +55.3%
- Net income
- +52.1%
- EPS
- +57.5%
- Free cash flow
- -4.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026